financetom
Business
financetom
/
Business
/
Lufthansa sees 2024 operating results on par with last year as costs rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Lufthansa sees 2024 operating results on par with last year as costs rise
Mar 7, 2024 1:12 AM

LONDON/FRANKFURT, March 7 (Reuters) - Lufthansa

reported on Thursday an operating profit of 2.7

billion euros for 2023 as expected and said 2024 operating

results will be on par with last year as the German airline

struggles with costly labour disputes.

The impact of strikes and a drop in logistics profits

will lead to a higher expected operating loss in the first

quarter than in earlier years, the German airline said,

offsetting strong post-COVID travel demand.

"The group remains committed to its goal of generating a

sustainable adjusted EBIT margin of at least 8 percent," the

company said in a statement.

Europe's airlines have benefited from unprecedented

demand after the pandemic, allowing them to raise

prices

, but higher labour and maintenance costs have

limited

earnings growth.

Lufthansa in particular has agreed to new, higher pay

deals to end strikes, which analysts and investors say

threatens

its 2024 operating margin target.

On Wednesday, its cabin staff

voted

to go on strike as they seek a 15% wage increase, a

potential harbinger of further profit erosion.

The results come almost two weeks after the airline

announced the

surprise

departure of respected chief financial officer Remco

Steenbergen, which knocked its share price and rattled investor

confidence.

Operating profits for 2023 were up 76% from 1.5 billion

euros ($1.63 billion) in 2022. Revenues of 35.4 billion euros

($38.58 billion) were up almost 15% over 31 billion euros

($33.79 billion) in 2022, but were lower than the 36.3 billion

euros ($39.56 billion) expected in a company-issued poll.

DIVIDEND

Despite the adjustment in operating margin target, the

company said its results were strong enough to propose issuing a

divided of 0.30 euros a share, to be voted on at the annual

general meeting on May 7.

The group has not issued a dividend since 2019.

The carrier's shares have outperformed European rival

flag carriers Air France-KLM and IAG since

early 2022 as the region's travel industry recovered from

disruption caused by the COVID-19 pandemic worldwide since 2020.

Last week, results from Air France and British Airways

owner IAG put the spotlight on challenges for the industry from

high prices of jet fuel, to geopolitical flashpoints, problems

at plane makers and wage talks.

Lufthansa shares trade at five times forecast earnings

over the next 12 months, compared to four times for IAG and

three for Air France-KLM.

($1=0.9175 euros)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
India's Reliance to stop buying Venezuelan oil over US tariffs, sources say
India's Reliance to stop buying Venezuelan oil over US tariffs, sources say
Mar 26, 2025
NEW DELHI (Reuters) - India's Reliance Industries, operator of the world's biggest refining complex, will halt Venezuelan oil imports after the United States announced a 25% tariff on nations buying crude from the South American nation, three sources said on Wednesday. The Indian conglomerate, which last year obtained approval from U.S. authorities to purchase oil from the sanctioned producer, imports...
Phillips 66 Nominates Four Board Members in Proxy Statement Amid Shareholder Lawsuit
Phillips 66 Nominates Four Board Members in Proxy Statement Amid Shareholder Lawsuit
Mar 26, 2025
08:15 AM EDT, 03/26/2025 (MT Newswires) -- Phillips 66 (PSX) said Wednesday it has nominated four candidates to stand for election to the board of directors ahead of the upcoming annual shareholders' meeting. The company said the nominees include current directors John Lowe and Robert Pease, and new nominees A. Nigel Hearne and Howard Ungerleider, who will replace retiring directors...
BRIEF-Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Announces Its Novel Inhibitors Show Promising In Silico Activity Against Measles And Related Viruses
BRIEF-Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Announces Its Novel Inhibitors Show Promising In Silico Activity Against Measles And Related Viruses
Mar 26, 2025
March 26 (Reuters) - Salarius Pharmaceuticals Inc ( SLRX ) : * SALARIUS PHARMACEUTICALS MERGER PARTNER, DECOY THERAPEUTICS, ANNOUNCES ITS NOVEL INHIBITORS SHOW PROMISING IN SILICO ACTIVITY AGAINST MEASLES AND RELATED VIRUSES Source text: Further company coverage: ...
OSR Unit Vaximm Reports Positive Results for Brain Cancer Therapy; Shares Jump
OSR Unit Vaximm Reports Positive Results for Brain Cancer Therapy; Shares Jump
Mar 26, 2025
08:13 AM EDT, 03/26/2025 (MT Newswires) -- OSR (OSRH) subsidiary Vaximm said Wednesday that final data from a phase 2a trial showed that its investigational vaccine VXM01 in combination with avelumab could offer meaningful clinical benefit in patients with recurrent glioblastoma, a type of aggressive brain cancer. The 25-patient trial also showed that the VXM01-avelumab combination therapy was well-tolerated and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved